Skip to main content

Month: August 2020

Targa Resources Partners LP Announces Tender Offer for Its 6.750% Senior Notes due 2024

HOUSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) — Targa Resources Partners LP (“Targa Resources Partners” or the “Partnership”), a subsidiary of Targa Resources Corp. (NYSE:TRGP) announced today that it has commenced a cash tender offer (the “Tender Offer”) to purchase any and all of the outstanding senior notes listed in the following table upon the terms and conditions described in the Partnership’s Offer to Purchase dated August 11, 2020 (the “Offer to Purchase”).____________________(1) Targa Resources Partners Finance Corporation, a wholly owned subsidiary of the Partnership, is a co-issuer of these securities.Holders whose notes are purchased will also receive accrued and unpaid interest thereon from the last interest payment date up to, but not including, the initial settlement date.The Tender Offer is being made pursuant to the terms...

Continue reading

Targa Resources Partners LP Announces $750.0 Million Offering of Senior Notes

HOUSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) — Targa Resources Partners LP (the “Partnership”), a subsidiary of Targa Resources Corp. (NYSE: TRGP), and the Partnership’s subsidiary Targa Resources Partners Finance Corporation announced today that, subject to market conditions, they intend to sell in an offering in the United States to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and to persons outside of the United States pursuant to Regulation S under the Securities Act, $750.0 million in aggregate principal amount of senior unsecured notes due 2031. The Partnership intends to use a portion of the net proceeds from the offering to fund the concurrent cash tender offer (the “Tender Offer”) to purchase for cash, subject to certain conditions, any and all of the...

Continue reading

Trxade Group Announces Launch of Bonum+ B2B Platform

Bonum+ Bundles Telehealth, a COVID-19 Risk Assessment Tool and a PPE Purchasing Tool, through a Secure Mobile Dashboard for Corporate ClientsTAMPA, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) — Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that its Bonum Health subsidiary has launched a first-of-its-kind Business-to-Business (B2B) platform called Bonum+, which bundles telehealth, a COVID-19 risk assessment tool and a Personal Protective Equipment (PPE) purchasing tool, through a secure mobile dashboard for corporate clients.The new B2B platform eases pressure on employees who are required to report any relevant health issues daily, centralizing communication and contact tracing to deliver risk scores. This allows employers to monitor employee COVID-19 risk profiles and...

Continue reading

Cerberus Sentinel announces acquisition of Technologyville  

SCOTTSDALE, Ariz., Aug. 11, 2020 (GLOBE NEWSWIRE) — Cerberus Cyber Sentinel Corporation (OTC: CISO), a cybersecurity consulting and managed services firm based in Scottsdale, Arizona, has acquired Technologyville, Inc.,  a Chicago-based managed security services provider (MSSP).Under the terms of the agreement, Technologyville is now a wholly owned subsidiary of Cerberus Sentinel and will continue to focus on providing managed IT services to a diverse set of U.S. customers.  With the new organizational structure, Technologyville president and founder, Brian Yelm, will take on the role of managing director for Cerberus Sentinel.“As businesses continue to rely more and more on technology, we have increasing responsibility, as IT people, to ensure the safety of their data and intellectual property,” said Yelm. “By joining with a national...

Continue reading

TM – Afkomuviðvörun

Áætlaður hagnaður TM og dótturfélaga á öðrum ársfjórðungi um 1,6 milljarðar krónaDrög að uppgjöri annars ársfjórðungs 2020 hafa leitt í ljós að afkoma TM samstæðunnar er umtalsvert betri en gert hafði verið ráð fyrir, hvort heldur litið sé til síðustu birtu rekstrarspár fyrir fjórðunginn eða þess hvernig félagið mat horfur ársins við birtingu uppgjörs fyrsta ársfjórðungs.Hagnaður á fjórðungnum er áætlaður um 1,6 milljarðar króna fyrir skatta og skýrist einkum af bættri afkomu af vátryggingastarfsemi og fjárfestingum. Samsett hlutfall á fjórðungnum er um 90%, fjárfestingatekjur námu um 1,6 milljörðum króna og hagnaður af fjármögnunarstarfsemi Lykils nam um 80 milljónum.Áréttað er að framangreindar upplýsingar eru birtar með þeim fyrirvara að um drög að uppgjöri er að ræða. Uppgjör annars ársfjórðungs verður birt þann 26. ágúst nk. og kynningarfundur...

Continue reading

Arch Therapeutics Novel Self-Assembling Agent, AC5-GTM, for Use in Endoscopic Procedures was Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting

FRAMINGHAM, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, announces the release of research from the AC5® self-assembling peptide technology platform that was presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting.SAGES selected the research, originally submitted as an abstract, to be featured in a podium presentation with a demonstration video as part of the Emerging Technology Session.1 The presentation, “Novel Self-assembling Agent, AC5-GTM, for Use in Submucosal Lifting in Endoscopic Resection and Management of Gastrointestinal Bleeding” by Eleanor C. Fung, MD, Jay Redan, MD, Chirag Shah, PhD and Terrence Norchi, MD, is...

Continue reading

Arcturus Therapeutics Announces that it has Initiated Dosing of its COVID-19 STARR™ mRNA Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 study

Potential for highly differentiated COVID-19 vaccine profile with a single administration, at a low doseClinical study data expected in Q4 2020SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that all subjects in the first cohort have been dosed in the Phase 1/2 clinical study with its ARCT-021 investigational vaccine for COVID-19. The study is being conducted with CTI Clinical Trial and Consulting Services, a global CRO, and in collaboration with Duke-NUS Medical School in Singapore.“We are very pleased to have initiated dosing in our ARCT-021 Phase 1/2...

Continue reading

Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

CAMBRIDGE, Mass. and NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today reported financial results for the second quarter ended June 30, 2020, and provided a corporate update.“Throughout the quarter, we have made meaningful progress in executing on our strategic goals, as we continue to advance the clinical program for BDTX-189 through the enrollment and dosing of patients in the Phase 1 portion of the MasterKey-01 trial,” said David Epstein, Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. “In parallel, we continue to invest in and advance our early stage pipeline and expand our proprietary MAP platform technology. We’ve taken critical...

Continue reading

SurveyMonkey Launches Tech Partner Program

SAN MATEO, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK), a leader in agile software solutions for customer experience, market research, and survey feedback, today announced the launch of the SurveyMonkey Technology Ecosystem Program (STEP), an expanded partner platform that addresses enterprises’ growing and evolving needs to generate stakeholder feedback and channel it into direct action.Built on an already-robust partner ecosystem, STEP will help companies of all sizes build, launch, amplify, and scale their SurveyMonkey integrations with developer resources and go-to-market opportunities provided by SurveyMonkey. Existing STEP partners include Zendesk, HubSpot, MailChimp, Constant Contact, Gainsight, and Freshworks, all of whom are integrating with SurveyMonkey to enable joint users to leverage the power...

Continue reading

Middlefield Banc Corp. Announces 2020 Third Quarter Cash Dividend Payment

MIDDLEFIELD, Ohio, Aug. 11, 2020 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today announced that the Company’s Board of Directors declared a quarterly cash dividend of $0.15 per common share payable on September 15, 2020, to shareholders of record on September 4, 2020. The quarterly dividend has been adjusted to reflect the two-for-one stock split on November 8, 2019.  About Middlefield Banc Corp.Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the bank holding company of The Middlefield Banking Company with total assets of $1.34 billion at June 30, 2020. The bank operates 16 full-service banking centers and an LPL Financial® brokerage office serving Beachwood, Chardon, Cortland, Dublin, Garrettsville, Mantua, Middlefield, Newbury, Orwell, Plain City, Powell, Solon, Sunbury, Twinsburg, and Westerville....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.